Table 7.
Comparison of ELISA data to the FRNA NT50.
Sample | FRNA NT50 | R&D ELISA SARS-CoV-2 |
EURO ELISA SARS-CoV-2 |
|||||
---|---|---|---|---|---|---|---|---|
Rep 1 | Rep 2 | Rep 1 | Rep 2 | Rep 3 | Rep 1 | Rep 2 | Rep 3 | |
1 | <40 | 80 | + | + | + | + | + | + |
2 * | 40 | 40 | + | - | - | + | + | + |
3 | <40 | <40 | - | + | + | - | - | - |
4 | <40 | <40 | + | + | + | + | + | + |
5 | <40 | <40 | - | - | - | - | - | - |
6 | <40 | <40 | + | + | + | + | + | + |
7 | 160 | 80 | + | + | + | + | + | + |
8 | 80 | 40 | + | + | + | + | + | + |
9 | 640 | 320 | + | + | + | + | + | + |
10 | 80 | 80 | + | + | + | + | + | + |
11 | 160 | 80 | + | + | + | + | + | + |
12 | 320 | 320 | + | + | + | + | + | + |
13 | <40 | <40 | - | - | - | - | - | - |
14 | <40 | <40 | - | - | - | - | - | - |
15 | 80 | <40 | + | + | + | + | + | + |
16 | <40 | <40 | - | - | - | - | - | - |
17 | <40 | <40 | - | - | - | - | - | - |
18 | 40 | <40 | + | + | + | + | + | + |
19 | 320 | 40 | + | + | + | + | + | + |
20 | <40 | 40 | - | - | - | - | - | - |
21 | 80 | <40 | + | + | + | + | + | + |
22 | 80 | 80 | + | + | + | + | + | + |
23 | <40 | <40 | - | - | - | - | - | - |
24 | 40 | <40 | + | + | + | + | + | + |
25 | <40 | <40 | - | - | - | - | - | - |
26 | <40 | <40 | - | - | - | - | - | - |
27 | <40 | <40 | + | + | + | + | + | + |
28 | 80 | <40 | + | + | + | + | + | + |
29 | 80 | 80 | + | + | + | + | + | + |
30 | <40 | <40 | + | + | + | + | + | + |
Positive Control | 80 | 80 | + | + | + | + | + | + |
* Gray shaded rows indicate samples with variability between ELISA and NT50 results. FRNA = fluorescence reduction neutralization assay. NT50 = 50% neutralizing titer. ELISA = Enzyme-Linked ImmunoSorbent Assay. R&D = R&D Systems. EURO = EuroImmun.